{"transactions":[{"id":520885,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2010-03-16T20:18:40.000Z","date":"2010-03-15","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Right to buy under under 1996 Stock and Option Plan, fully vested on grant date, 6/1/2000."}],"balance_after":0,"derivative":{"exercise_price":38.44,"exercise_date":"2000-06-01","expiration_date":"2010-05-31","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000875320-10-000015","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532010000015/edgar.xml","form_type":"4"}},{"id":520884,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2010-03-16T20:18:40.000Z","date":"2010-03-15","kind":"sale","acquired":false,"shares":10000,"price":43.1,"value":431000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Brimblecombe's company approved sales plan established under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $43.10 (range $42.80 to $43.52)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Dr. Brimblecombe undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000875320-10-000015","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532010000015/edgar.xml","form_type":"4"}},{"id":520883,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2010-03-16T20:18:40.000Z","date":"2010-03-15","kind":"exercise","acquired":true,"shares":10000,"price":38.44,"value":384400.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0000875320-10-000015","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532010000015/edgar.xml","form_type":"4"}},{"id":530218,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2009-06-03T18:45:29.000Z","date":"2009-06-01","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Right to buy under 2006 Stock and Option Plan. Fully vested."}],"balance_after":20000,"derivative":{"exercise_price":29.89,"exercise_date":"2009-06-01","expiration_date":"2019-05-31","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000875320-09-000042","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000042/edgar.xml","form_type":"4"}},{"id":544165,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2008-06-02T20:46:33.000Z","date":"2008-06-01","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Right to buy under 2006 Stock and Option Plan.  Fully vested."}],"balance_after":20000,"derivative":{"exercise_price":28.4,"exercise_date":"2008-06-01","expiration_date":"2018-05-31","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000875320-08-000040","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000040/edgar.xml","form_type":"4"}},{"id":544896,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2008-05-28T17:58:03.000Z","date":"2008-05-27","kind":"grant","acquired":false,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 1996 Stock and Option Plan, fully vested on grant date, 6/1/1998."}],"balance_after":0,"derivative":{"exercise_price":14.2,"exercise_date":"1998-06-01","expiration_date":"2008-05-31","underlying":"Common Stock","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0000875320-08-000034","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000034/edgar.xml","form_type":"4"}},{"id":544895,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2008-05-28T17:58:03.000Z","date":"2008-05-27","kind":"sale","acquired":false,"shares":333,"price":27.16,"value":9044.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Brimblecombe's company approved sales plan established under Rule 10b5-1."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000875320-08-000034","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000034/edgar.xml","form_type":"4"}},{"id":544894,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2008-05-28T17:58:03.000Z","date":"2008-05-27","kind":"sale","acquired":false,"shares":333,"price":26.99,"value":8987.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Brimblecombe's company approved sales plan established under Rule 10b5-1."}],"balance_after":333,"source":{"system":"sec-edgar","filing":"0000875320-08-000034","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000034/edgar.xml","form_type":"4"}},{"id":544893,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2008-05-28T17:58:03.000Z","date":"2008-05-27","kind":"sale","acquired":false,"shares":334,"price":26.84,"value":8964.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Brimblecombe's company approved sales plan established under Rule 10b5-1."}],"balance_after":666,"source":{"system":"sec-edgar","filing":"0000875320-08-000034","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000034/edgar.xml","form_type":"4"}},{"id":544892,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2008-05-28T17:58:03.000Z","date":"2008-05-27","kind":"sale","acquired":false,"shares":333,"price":26.75,"value":8907.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Brimblecombe's company approved sales plan established under Rule 10b5-1."}],"balance_after":1000,"source":{"system":"sec-edgar","filing":"0000875320-08-000034","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000034/edgar.xml","form_type":"4"}},{"id":544891,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2008-05-28T17:58:03.000Z","date":"2008-05-27","kind":"sale","acquired":false,"shares":333,"price":26.71,"value":8894.43,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Brimblecombe's company approved sales plan established under Rule 10b5-1."}],"balance_after":1333,"source":{"system":"sec-edgar","filing":"0000875320-08-000034","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000034/edgar.xml","form_type":"4"}},{"id":544890,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2008-05-28T17:58:03.000Z","date":"2008-05-27","kind":"sale","acquired":false,"shares":666,"price":26.68,"value":17768.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Brimblecombe's company approved sales plan established under Rule 10b5-1."}],"balance_after":1666,"source":{"system":"sec-edgar","filing":"0000875320-08-000034","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000034/edgar.xml","form_type":"4"}},{"id":544889,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2008-05-28T17:58:03.000Z","date":"2008-05-27","kind":"sale","acquired":false,"shares":334,"price":26.66,"value":8904.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Brimblecombe's company approved sales plan established under Rule 10b5-1."}],"balance_after":2332,"source":{"system":"sec-edgar","filing":"0000875320-08-000034","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000034/edgar.xml","form_type":"4"}},{"id":544888,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2008-05-28T17:58:03.000Z","date":"2008-05-27","kind":"sale","acquired":false,"shares":334,"price":26.54,"value":8864.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Brimblecombe's company approved sales plan established under Rule 10b5-1."}],"balance_after":2666,"source":{"system":"sec-edgar","filing":"0000875320-08-000034","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000034/edgar.xml","form_type":"4"}},{"id":544887,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2008-05-28T17:58:03.000Z","date":"2008-05-27","kind":"sale","acquired":false,"shares":333,"price":26.4,"value":8791.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Brimblecombe's company approved sales plan established under Rule 10b5-1."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0000875320-08-000034","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000034/edgar.xml","form_type":"4"}},{"id":544886,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2008-05-28T17:58:03.000Z","date":"2008-05-27","kind":"exercise","acquired":true,"shares":3333,"price":14.2,"value":47328.6,"ownership":{"direct":true},"balance_after":3333,"source":{"system":"sec-edgar","filing":"0000875320-08-000034","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000034/edgar.xml","form_type":"4"}},{"id":545933,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2008-05-21T19:38:13.000Z","date":"2008-05-20","kind":"grant","acquired":false,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 1996  Stock and Option Plan, fully vested on grant date, 6/1/1998."}],"balance_after":3333,"derivative":{"exercise_price":14.2,"exercise_date":"1998-09-01","expiration_date":"2008-05-31","underlying":"Common Stock","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0000875320-08-000028","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000028/edgar.xml","form_type":"4"}},{"id":545932,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2008-05-21T19:38:13.000Z","date":"2008-05-20","kind":"sale","acquired":false,"shares":333,"price":27.68,"value":9217.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Brimblecombe's company approved sales plan established under Rule 10b5-1."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000875320-08-000028","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000028/edgar.xml","form_type":"4"}},{"id":545931,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common  Stock","published_at":"2008-05-21T19:38:13.000Z","date":"2008-05-20","kind":"sale","acquired":false,"shares":667,"price":27.47,"value":18322.49,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Brimblecombe's company approved sales plan established under Rule 10b5-1."}],"balance_after":333,"source":{"system":"sec-edgar","filing":"0000875320-08-000028","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000028/edgar.xml","form_type":"4"}},{"id":545930,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2008-05-21T19:38:13.000Z","date":"2008-05-20","kind":"sale","acquired":false,"shares":333,"price":27.73,"value":9234.09,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Brimblecombe's company approved sales plan established under Rule 10b5-1."}],"balance_after":1000,"source":{"system":"sec-edgar","filing":"0000875320-08-000028","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000028/edgar.xml","form_type":"4"}},{"id":545929,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2008-05-21T19:38:13.000Z","date":"2008-05-20","kind":"sale","acquired":false,"shares":667,"price":27.71,"value":18482.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Brimblecombe's company approved sales plan established under Rule 10b5-1."}],"balance_after":1333,"source":{"system":"sec-edgar","filing":"0000875320-08-000028","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000028/edgar.xml","form_type":"4"}},{"id":545928,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2008-05-21T19:38:13.000Z","date":"2008-05-20","kind":"sale","acquired":false,"shares":333,"price":27.61,"value":9194.13,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Brimblecombe's company approved sales plan established under Rule 10b5-1."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0000875320-08-000028","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000028/edgar.xml","form_type":"4"}},{"id":545927,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2008-05-21T19:38:13.000Z","date":"2008-05-20","kind":"sale","acquired":false,"shares":333,"price":27.59,"value":9187.47,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Brimblecombe's company approved sales plan established under Rule 10b5-1."}],"balance_after":2333,"source":{"system":"sec-edgar","filing":"0000875320-08-000028","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000028/edgar.xml","form_type":"4"}},{"id":545926,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2008-05-21T19:38:13.000Z","date":"2008-05-20","kind":"sale","acquired":false,"shares":333,"price":27.58,"value":9184.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Brimblecombe's company approved sales plan established under Rule 10b5-1."}],"balance_after":2666,"source":{"system":"sec-edgar","filing":"0000875320-08-000028","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000028/edgar.xml","form_type":"4"}},{"id":545925,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2008-05-21T19:38:13.000Z","date":"2008-05-20","kind":"sale","acquired":false,"shares":334,"price":27.5,"value":9185.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Brimblecombe's company approved sales plan established under Rule 10b5-1."}],"balance_after":2999,"source":{"system":"sec-edgar","filing":"0000875320-08-000028","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000028/edgar.xml","form_type":"4"}},{"id":545924,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2008-05-21T19:38:13.000Z","date":"2008-05-20","kind":"exercise","acquired":true,"shares":3333,"price":14.2,"value":47328.6,"ownership":{"direct":true},"balance_after":3333,"source":{"system":"sec-edgar","filing":"0000875320-08-000028","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000028/edgar.xml","form_type":"4"}},{"id":547024,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2008-05-15T19:08:16.000Z","date":"2008-05-13","kind":"grant","acquired":false,"shares":3334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 1996 Stock and Option Plan, fully vested on grant date, 6/1/1998."}],"balance_after":6666,"derivative":{"exercise_price":14.2,"exercise_date":"1998-09-01","expiration_date":"2008-05-31","underlying":"Common Stock","underlying_shares":3334},"source":{"system":"sec-edgar","filing":"0000875320-08-000021","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000021/edgar.xml","form_type":"4"}},{"id":547023,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2008-05-15T19:08:16.000Z","date":"2008-05-13","kind":"sale","acquired":false,"shares":334,"price":27.7,"value":9251.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Brimblecombe's company approved trading plan established under Rule 10b5-1."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000875320-08-000021","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000021/edgar.xml","form_type":"4"}},{"id":547022,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2008-05-15T19:08:16.000Z","date":"2008-05-13","kind":"sale","acquired":false,"shares":300,"price":27.46,"value":8238.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Brimblecombe's company approved trading plan established under Rule 10b5-1."}],"balance_after":334,"source":{"system":"sec-edgar","filing":"0000875320-08-000021","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000021/edgar.xml","form_type":"4"}},{"id":547021,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2008-05-15T19:08:16.000Z","date":"2008-05-13","kind":"sale","acquired":false,"shares":300,"price":27.27,"value":8181.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Brimblecombe's company approved trading plan established under Rule 10b5-1."}],"balance_after":634,"source":{"system":"sec-edgar","filing":"0000875320-08-000021","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000021/edgar.xml","form_type":"4"}},{"id":547020,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2008-05-15T19:08:16.000Z","date":"2008-05-13","kind":"sale","acquired":false,"shares":500,"price":27.19,"value":13595.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Brimblecombe's company approved trading plan established under Rule 10b5-1."}],"balance_after":934,"source":{"system":"sec-edgar","filing":"0000875320-08-000021","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000021/edgar.xml","form_type":"4"}},{"id":547019,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2008-05-15T19:08:16.000Z","date":"2008-05-13","kind":"sale","acquired":false,"shares":100,"price":27.14,"value":2714.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Brimblecombe's company approved trading plan established under Rule 10b5-1."}],"balance_after":1434,"source":{"system":"sec-edgar","filing":"0000875320-08-000021","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000021/edgar.xml","form_type":"4"}},{"id":547018,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2008-05-15T19:08:16.000Z","date":"2008-05-13","kind":"sale","acquired":false,"shares":200,"price":27.13,"value":5426.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Brimblecombe's company approved trading plan established under Rule 10b5-1."}],"balance_after":1534,"source":{"system":"sec-edgar","filing":"0000875320-08-000021","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000021/edgar.xml","form_type":"4"}},{"id":547017,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2008-05-15T19:08:16.000Z","date":"2008-05-13","kind":"sale","acquired":false,"shares":300,"price":27.08,"value":8124.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Brimblecombe's company approved trading plan established under Rule 10b5-1."}],"balance_after":1734,"source":{"system":"sec-edgar","filing":"0000875320-08-000021","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000021/edgar.xml","form_type":"4"}},{"id":547016,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2008-05-15T19:08:16.000Z","date":"2008-05-13","kind":"sale","acquired":false,"shares":300,"price":27.07,"value":8121.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Brimblecombe's company approved trading plan established under Rule 10b5-1."}],"balance_after":2034,"source":{"system":"sec-edgar","filing":"0000875320-08-000021","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000021/edgar.xml","form_type":"4"}},{"id":547015,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2008-05-15T19:08:16.000Z","date":"2008-05-13","kind":"sale","acquired":false,"shares":300,"price":27.03,"value":8109.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Brimblecombe's company approved trading plan established under Rule 10b5-1."}],"balance_after":2334,"source":{"system":"sec-edgar","filing":"0000875320-08-000021","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000021/edgar.xml","form_type":"4"}},{"id":547014,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2008-05-15T19:08:16.000Z","date":"2008-05-13","kind":"sale","acquired":false,"shares":700,"price":27,"value":18900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Brimblecombe's company approved trading plan established under Rule 10b5-1."}],"balance_after":2634,"source":{"system":"sec-edgar","filing":"0000875320-08-000021","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000021/edgar.xml","form_type":"4"}},{"id":547013,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2008-05-15T19:08:16.000Z","date":"2008-05-13","kind":"exercise","acquired":true,"shares":3334,"price":14.2,"value":47342.8,"ownership":{"direct":true},"balance_after":3334,"source":{"system":"sec-edgar","filing":"0000875320-08-000021","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000021/edgar.xml","form_type":"4"}},{"id":578578,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2007-06-04T16:48:29.000Z","date":"2007-06-01","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Right to buy under 2006 Stock and Option Plan.  Fully vested."}],"balance_after":20000,"derivative":{"exercise_price":29.84,"exercise_date":"2007-06-01","expiration_date":"2017-05-31","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000875320-07-000062","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000062/edgar.xml","form_type":"4"}},{"id":582820,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2007-04-11T20:18:10.000Z","date":"2007-04-10","kind":"grant","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 1996 Stock and Option Plan, fully vested on grant date, 6/1/1997."}],"balance_after":0,"derivative":{"exercise_price":19.78,"exercise_date":"1997-06-01","expiration_date":"2007-05-31","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000875320-07-000037","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000037/edgar.xml","form_type":"4"}},{"id":582819,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2007-04-11T20:18:10.000Z","date":"2007-04-10","kind":"sale","acquired":false,"shares":10000,"price":32.36,"value":323600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Brimblecombe's company approved trading plan established under Rule 10b5-1."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000875320-07-000037","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000037/edgar.xml","form_type":"4"}},{"id":582818,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2007-04-11T20:18:10.000Z","date":"2007-04-10","kind":"exercise","acquired":true,"shares":10000,"price":19.78,"value":197800.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0000875320-07-000037","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000037/edgar.xml","form_type":"4"}},{"id":606682,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2006-06-02T17:13:54.000Z","date":"2006-06-01","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Right to buy under 2006 Stock and Option Plan.  Fully vested."}],"balance_after":72500,"derivative":{"exercise_price":34.32,"exercise_date":"2006-06-01","expiration_date":"2016-05-31","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000875320-06-000050","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000050/edgar.xml","form_type":"4"}},{"id":618432,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2006-02-14T18:53:18.000Z","date":"2006-02-13","kind":"grant","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Right to buy under 1996 Stock and Option Plan, fully vested on grant date, 6/1/2005."}],"balance_after":52500,"derivative":{"exercise_price":13.32,"exercise_date":"2005-06-01","expiration_date":"2015-05-31","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000875320-06-000019","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000019/edgar.xml","form_type":"4"}},{"id":618431,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2006-02-14T18:53:18.000Z","date":"2006-02-13","kind":"grant","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 1996 Stock and Option Plan, fully vested on grant date, 6/1/2004."}],"balance_after":62500,"derivative":{"exercise_price":9.09,"exercise_date":"2004-06-01","expiration_date":"2014-05-31","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0000875320-06-000019","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000019/edgar.xml","form_type":"4"}},{"id":618430,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2006-02-14T18:53:18.000Z","date":"2006-02-13","kind":"grant","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Right to buy under 1996 Stock and Option Plan, fully vested on grant date, 6/1/1999."}],"balance_after":70000,"derivative":{"exercise_price":10.05,"exercise_date":"1999-06-01","expiration_date":"2009-05-31","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000875320-06-000019","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000019/edgar.xml","form_type":"4"}},{"id":618429,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2006-02-14T18:53:18.000Z","date":"2006-02-13","kind":"sale","acquired":false,"shares":10000,"price":35.19,"value":351900.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0000875320-06-000019","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000019/edgar.xml","form_type":"4"}},{"id":618428,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2006-02-14T18:53:18.000Z","date":"2006-02-13","kind":"exercise","acquired":true,"shares":10000,"price":13.32,"value":133200.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0000875320-06-000019","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000019/edgar.xml","form_type":"4"}},{"id":618427,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2006-02-14T18:53:18.000Z","date":"2006-02-13","kind":"sale","acquired":false,"shares":7500,"price":35.19,"value":263925.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0000875320-06-000019","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000019/edgar.xml","form_type":"4"}},{"id":618426,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2006-02-14T18:53:18.000Z","date":"2006-02-13","kind":"exercise","acquired":true,"shares":7500,"price":9.09,"value":68175.0,"ownership":{"direct":true},"balance_after":7500,"source":{"system":"sec-edgar","filing":"0000875320-06-000019","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000019/edgar.xml","form_type":"4"}},{"id":618425,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2006-02-14T18:53:18.000Z","date":"2006-02-13","kind":"sale","acquired":false,"shares":10000,"price":35.19,"value":351900.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0000875320-06-000019","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000019/edgar.xml","form_type":"4"}},{"id":618424,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2006-02-14T18:53:18.000Z","date":"2006-02-13","kind":"exercise","acquired":true,"shares":10000,"price":10.05,"value":100500.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0000875320-06-000019","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000019/edgar.xml","form_type":"4"}},{"id":638726,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2005-06-03T14:45:10.000Z","date":"2005-06-01","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Right to buy under 1996 Stock and Option Plan.  Fully vested."}],"balance_after":80000,"derivative":{"exercise_price":13.32,"exercise_date":"2005-06-01","expiration_date":"2015-05-31","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000875320-05-000024","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532005000024/edgar.xml","form_type":"4"}},{"id":656390,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2004-06-02T15:06:27.000Z","date":"2004-06-01","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Right to buy under 1996 Stock and Option Plan.  Fully vested."}],"balance_after":70000,"derivative":{"exercise_price":9.09,"exercise_date":"2004-06-01","expiration_date":"2014-05-31","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0000875320-04-000065","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532004000065/edgar.xml","form_type":"4"}},{"id":670188,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16995,"kind":"person","name":"BRIMBLECOMBE ROGER W","position":1,"cik":"0001197034","reported_name":"BRIMBLECOMBE ROGER W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2003-06-03T18:36:19.000Z","date":"2003-06-01","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Right to buy under the 1996 Stock and Option Plan. Fully vested."}],"balance_after":62500,"derivative":{"exercise_price":14.46,"exercise_date":"2003-06-01","expiration_date":"2013-05-31","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0000875320-03-000010","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532003000010/edgar.xml","form_type":"4"}}]}